Ticarcillin is a semi-synthetic penicillin used primarily for the treatment of severe Gram-negative bacterial infections, particularly those caused by Pseudomonas aeruginosa, against which it exhibits 2–4 times greater activity than carbenicillin. It has a broader spectrum of activity similar to carbenicillin but shows relatively lower activity against Gram-positive bacteria and higher efficacy against Gram-negative organisms. Clinically, ticarcillin is commonly formulated in combination with potassium clavulanate (as ticarcillin disodium/clavulanate potassium) to broaden its antibacterial spectrum and enhance its antimicrobial potency through β-lactamase inhibition.